ivosidenib
servier
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'ivosidenib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
congress | #eha2023 | poster eytan stein, highlights the clinical and molecular characteristics of exceptional responders to ivosidenib in patients with r/r midh1 aml. progressive reduction of midh1 in the bm was associated with a prolonged response. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm